Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Hold | 9,467,383 | $64.45 | $610M | — | — | |
| FLR - Fluor | Reduce −14.6% | 4,747,350 | $46.65 | $221M | −808,550 | +$1M | |
| CNR - Core Natural Resources | Reduce −11.5% | 1,858,140 | $104.73 | $195M | −242,340 | +$9M | |
| BHF - Brighthouse Finl | Add +1.8% | 2,842,100 | $59.88 | $170M | +50,000 | −$11M | |
| PCG - Pg And E | Reduce −14.8% | 6,632,852 | $17.57 | $117M | −1,151,251 | −$9M | |
| VSNT - Versant Media Group · CL A | New | 3,028,615 | $37.02 | $112M | +3,028,615 | +$112M | |
| ACHC — | Add +9.6% | 4,518,381 | $23.39 | $106M | +397,178 | +$47M | |
| VSXY - Victorias Secret And | Add +29.9% | 2,256,889 | $46.36 | $105M | +519,020 | +$10M | |
| DHT — | Reduce −28.4% | 5,272,770 | $18.27 | $96M | −2,093,894 | +$6M | |
| PENN - Penn Entertainment | Hold | 6,044,440 | $15.03 | $91M | — | — | |
| PKG - Graphic Packaging | Add +8.1% | 9,099,980 | $9.94 | $90M | +684,870 | −$36M | |
| CNC - Centene Del | Add +3.5% | 2,731,810 | $32.74 | $89M | +92,390 | −$19M | |
| TEVA - Teva Pharmaceutical Inds | Reduce −4.8% | 2,910,729 | $30.12 | $88M | −148,005 | −$8M | |
| CPRI - Capri | Add +3.4% | 4,930,318 | $17.62 | $87M | +162,311 | −$29M | |
| SNX - Td Synnex | Add +748.9% | 479,530 | $168.71 | $81M | +423,040 | +$72M | |
| BKV — | Add +109.3% | 2,695,543 | $28.52 | $77M | +1,407,600 | +$42M | |
| LBTYA - Liberty Global · CL A | Reduce −0.8% | 4,963,322 | $12.09 | $60M | −41,110 | +$4M | |
| ROIV - Roivant Sciences | Add +4.0% | 2,152,669 | $27.70 | $60M | +83,360 | +$15M | |
| CROX - Crocs | New | 669,140 | $83.02 | $56M | +669,140 | +$56M | |
| REZI - Resideo Technologies | New | 1,574,950 | $33.71 | $53M | +1,574,950 | +$53M | |
| DECK - Deckers Outdoor | Add +61.1% | 481,398 | $100.09 | $48M | +182,620 | +$17M | |
| SPB - Spectrum Brands | Reduce −2.0% | 650,359 | $73.70 | $48M | −13,531 | +$9M | |
| CNH - Cnh Indl | Reduce −27.4% | 4,188,940 | $11.00 | $46M | −1,578,600 | −$7M | |
| SLM — | New | 2,101,840 | $21.41 | $45M | +2,101,840 | +$45M | |
| HSIC - Schein Henry | Add +27.7% | 599,300 | $73.70 | $44M | +130,050 | +$9M | |
| PTON - Peloton Interactive · CL A | Add +4003.7% | 10,113,940 | $4.29 | $43M | +9,867,480 | +$42M | |
| GLD - Spdr Gold Tr | Reduce −41.6% | 99,611 | $430.29 | $43M | −70,950 | −$25M | |
| DCH - Dauch | New | 6,311,350 | $5.93 | $37M | +6,311,350 | +$37M | |
| PARA - Paramount Skydance · CL B | New | 3,926,080 | $9.02 | $35M | +3,926,080 | +$35M | |
| AR - Antero Resources | Reduce −20.3% | 808,520 | $42.44 | $34M | −205,550 | −$631K | |
| SLDE - Slide Ins | Add +46.7% | 1,686,630 | $18.00 | $30M | +536,750 | +$8M | |
| SHC - Sotera Health | Add +347.8% | 2,065,680 | $14.34 | $30M | +1,604,410 | +$21M | |
| STUB - Stubhub · CL A | New | 4,233,200 | $6.24 | $26M | +4,233,200 | +$26M | |
| VTRS - Viatris | New | 1,817,570 | $13.51 | $25M | +1,817,570 | +$25M | |
| CI - The Cigna Group | Reduce −5.7% | 88,400 | $266.75 | $24M | −5,350 | −$2M | |
| TCOM - Tripadvisor | New | 1,564,696 | $10.66 | $17M | +1,564,696 | +$17M | |
| LKFT - Galapagos | Hold | 482,746 | $30.00 | $14M | — | — | |
| WFRD - Weatherford Intl | Reduce −80.4% | 145,721 | $94.58 | $14M | −597,899 | −$44M | |
| ZIM - Zim Integrated | New | 354,526 | $26.35 | $9M | +354,526 | +$9M | |
| COYA - Coya Therapeutics | Add +15.3% | 2,335,540 | $3.94 | $9M | +309,600 | −$3M | |
| IMVT - Immunovant | New | 93,520 | $24.84 | $2M | +93,520 | +$2M | |
| GPRO - Gopro · CL A | Hold | 1,693,860 | $0.7700 | $1M | — | — | |
| GANX - Gain Therapeutics | Hold | 566,130 | $1.94 | $1M | — | — | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $4.29 | $150K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2025 Q4
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| KD - Kyndryl | Exit | 0 | $26.56 | $101M | −3,816,353 | −$101M | |
| WBD - Warner Bros Discovery | Exit | 0 | $28.82 | $44M | −1,533,080 | −$44M | |
| GPN - Global Pmts | Exit | 0 | $77.40 | $35M | −452,730 | −$35M | |
| United Parks & Resorts | Exit | 0 | $36.30 | $21M | −574,620 | −$21M | |
| GDX - Vaneck ETF Trust | Exit | 0 | $85.78 | $6M | −64,960 | −$6M | |
| KWEB - Kraneshares Trust | Exit | 0 | $34.05 | $4M | −131,510 | −$4M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2